PARTNERSHIP OPPORTUNITIES
Want to Become the Go-To Provider to Aid Drug Developers in their Mission to Develop RNA-Targeting Therapeutics?
The RNA targeting field is rapidly evolving with drug developers around the world racing to make best-in-class RNA targeting small molecule therapeutics for treating neurological disorders, oncological indications and more.
However, to achieve this, leading experts are looking to advance their early discovery, preclinical development and screening strategies, by working with service providers who have capabilities in genomic profiling, biophysical screening, assay development, RNA sequencing, discovery and preclinical services, NMR services and computational modelling.
Hence, this industry-dedicated summit is your premium opportunity to meet and network with RNA-targeting leaders from the likes of AstraZeneca, Sanofi, Biogen, Novartis, PTC Therapeutics, Remix Therapeutics, ReviR Therapeutics and more to generate leads, and better understand what tools and services the market wants and needs.
If you offer relevant services and want to maximize your company’s exposure, contact us today to discuss your bespoke commercial package at the 7th RNA Targeted Drug Discovery & Development Summit.
BENEFIT FROM MARKET INTELLIGENCE
With many new RNA-targeting approaches being developed, from splicing modulation to targeting long non-coding RNAs, hear how and where biopharma are searching for services and solutions to facilitate their RNA targeted drug discovery and match your solutions accordingly
With a room full of drug developers from the likes of Pfizer, Biogen, AstraZeneca, Sanofi, Expansion Therapeutics, Ribometrix and more, meet prospective clients during speed networking breaks and informal networking receptions to fuel commercial opportunities.
MEET & NETWORK IN-PERSON WITH INDUSTRY PIONEERS
POSITION YOURSELF AS AN INDUSTRY EXPERT
With the growing landscape of RNA targeting biotech companies, this meeting is a dedicated platform to put your independent expertise in front of the key decision-makers in the field.
Benefit from pre- and post- conference exposure to our comprehensive RNA-small molecules community as well as provide a wish-list of your choice to be contacted in advance to ensure you are set up for success at this valuable and dedicated meeting
RAISE BRAND AWARENESS & GENERATE COMMERCIAL COLLABORATIONS
For more information, email sponsor@hansonwade.com or download the full event guide here.
Perla Breccia
Senior Director, Chemistry
AstraZeneca
The future of drug discovery will be shaped by our understanding on how we will be able to modulate RNA, structure, and function.
Small molecules are ideal probes to interact with RNA and become drugs for the undruggable genome. Attending a meeting where KOLs come together and discuss and share openly their challenges and issues is very important to accelerate success in this emerging field
